The Role of Affect Regulation and Self-presentation in the Expressive Writing Intervention
Examining Potential Moderators and Mediators in the Expressive Writing Intervention: The Role of Affect Regulation and Self-presentation.
2 other identifiers
interventional
75
1 country
1
Brief Summary
The purpose of the present study is twofold. First, we will attempt to examine the role that emotion regulation and self-presentation play as potential moderators in the expressive writing paradigm. We hypothesize that expressive writing participants who demonstrate greater abilities to regulate their emotions at baseline will improve more on our outcome measures. We also hypothesize that those expressive writing participants who demonstrate higher levels of self-presentation at baseline will improve less on our outcome measures. The second aim of the study has two related objectives. First, we will attempt to investigate whether the expressive writing intervention can increase and enhance an individual's emotion regulation abilities. Related to this, we will then go on to examine whether emotion regulation can be looked at as a potential mechanism of action in the expressive writing procedure. Related to these two objectives, we hypothesize that in comparison to the control group, participants in the expressive writing condition will show increases in their ability to regulate their emotions from baseline to four week follow up. Moreover, we predict that greater gains in emotion regulation abilities for the expressive writing participants will be significantly related to greater gains in outcome measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2009
CompletedFirst Posted
Study publicly available on registry
January 29, 2009
CompletedStudy Start
First participant enrolled
February 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedMay 12, 2016
May 1, 2016
1.7 years
January 28, 2009
May 10, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Posttraumatic Stress Diagnostic Scale
Initial session; One month follow-up
Secondary Outcomes (3)
Difficulties in Emotion Regulation Scale
Initial session; One month follow-up
Pennebaker Inventory of Limbic Languidness
Initial session; One month follow-up
Beck Depression Inventory, Second Edition
Initial session; One month follow-up
Study Arms (2)
Expressive Writing
EXPERIMENTALControl
PLACEBO COMPARATORInterventions
Participants will write about their experienced trauma for 20 minutes on each of three consecutive days using techniques associated with expressive writing
Participants will write as factually as possible about an assigned trivial topic for 20 minutes on each of three consecutive days
Eligibility Criteria
You may qualify if:
- Fluent in English
- Previously experienced trauma (not current or ongoing; excluding bereavement)
- Currently experiencing trauma-related distress
You may not qualify if:
- Currently involved in psychotherapy
- Currently taking psychotropic medications
- Imminent threat to self or others
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ontario Institute for Studies in Education of the University of Toronto
Toronto, Ontario, M5S 1V6, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jeanne C Watson, Ph.D.
University of Toronto
- PRINCIPAL INVESTIGATOR
Justin M Mattina, M.A.
University of Toronto
- PRINCIPAL INVESTIGATOR
Jonathan J Danson, B.A.
University of Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 28, 2009
First Posted
January 29, 2009
Study Start
February 1, 2009
Primary Completion
November 1, 2010
Study Completion
November 1, 2010
Last Updated
May 12, 2016
Record last verified: 2016-05